May 29, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.
Jun 03, 2019 - The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast.
Jun 04, 2019 - Companies In The News Are:
Jun 06, 2019 - The annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago sees cancer data presentations from several drug/biotech companies about the latest developments in treating cancer.
Jun 10, 2019 - Roche (RHHBY) gets additional information request from FTC for the pending Spark acquisition.
Jun 12, 2019 - Merck's (MRK) Keytruda is already approved for use in 15 cancer indications across 10 different tumor types in the United States.
Jun 13, 2019 - Roche (RHHBY) announces positive data on rheumatic diseases drug, Rituxan, for pemphigus vulgaris.
Jun 14, 2019 - FDA approves Amgen (AMGN) and Allergan's Kanjiniti, a biosimilar version of Roche's (RHHBY) breast cancer drug, Herceptin.
Jun 18, 2019 - Pfizer could be only the first of several to spend billions buying smaller biotech.
Jun 19, 2019 - Key highlights of the past week include regulatory approvals, collaborations and pipeline updates.